ST-GLIPTIN M 100/500 is a trusted oral antidiabetic formulation designed to support better glycaemic control in adults with type 2 diabetes mellitus. It combines the proven effectiveness of Sitagliptin, a DPP-4 inhibitor, with Metformin Hydrochloride, a well-established biguanide class medicine. This dual-action therapy helps improve insulin response, reduce excess glucose production in the liver, and support long-term diabetes management. ST-GLIPTIN M 100/500 is typically prescribed when diet, physical activity, and single-medication therapy fail to achieve targeted blood sugar levels.
Uses
ST-GLIPTIN M 100/500 is primarily used for:
Management of type 2 diabetes mellitus in adults.
Lowering elevated blood sugar levels when monotherapy with Metformin or Sitagliptin is not adequate.Reducing post-meal glucose spikes by enhancing incretin hormone activity.
Supporting HbA1c improvement as part of a long-term diabetes treatment plan.
This combination is especially recommended for individuals who require a synergistic approach to achieve stable blood sugar control.
Benefits
This fixed-dose combination offers several clinical and lifestyle benefits:
1. Dual Mechanism for Better Control
Sitagliptin increases incretin levels, stimulating insulin release when required, while Metformin reduces glucose production in the liver and enhances insulin sensitivity.
2. Helps Maintain Consistent Blood Sugar Levels
The combination works throughout the day, reducing fasting glucose and post-meal sugar spikes more effectively than individual therapy.
3. Supports Weight Management
Metformin is known to assist in preventing weight gain, an important benefit for patients with type 2 diabetes.
4. Lower Risk of Hypoglycaemia
Due to its glucose-dependent mechanism, Sitagliptin reduces the risk of sudden low blood sugar episodes when compared to other classes of antidiabetic drugs.
5. Improves Long-Term Treatment Outcomes
Regular use as advised by the physician helps improve HbA1c values, reduces diabetes-related complications, and enhances overall quality of life.
Dosage
The dosage of ST-GLIPTIN M 100/500 should always be determined by a healthcare professional based on the patient’s blood sugar levels, response to therapy, and overall health condition.
It is usually taken once or twice daily, preferably with meals to minimise gastrointestinal discomfort associated with Metformin.
Swallow the tablet whole with water; do not crush or break it unless advised.
Regular blood sugar monitoring is recommended to assess treatment effectiveness.
Do not alter the dosage or discontinue the medicine without consulting your doctor.
Side Effects
Although ST-GLIPTIN M 100/500 is generally well-tolerated, some patients may experience:
Nausea or vomiting
Abdominal discomfort
Diarrhoea
Headache
Loss of appetite
Mild upper respiratory infections
Low Vitamin B12 levels (long-term Metformin use)
Rare but Serious Side Effects:
Lactic acidosis (a rare but serious complication linked to Metformin)
Severe joint pain
Pancreatitis symptoms such as persistent abdominal pain or nausea
Seek medical attention if any unusual or severe symptoms arise.
Precautions and Warning
Before starting ST-GLIPTIN M 100/500, keep the following precautions in mind:
1. Kidney and Liver Conditions
Patients with kidney impairment or liver disease must consult their doctor before use, as dosage adjustments may be necessary.
2. Alcohol Consumption
Avoid excessive alcohol intake, as it increases the risk of lactic acidosis.
3. Pregnancy and Breastfeeding
Use during pregnancy or breastfeeding should only occur under medical supervision.
4. Surgery or Radiological Procedures
Inform your doctor if you are scheduled for any surgery or contrast-based diagnostic procedure, as Metformin may need to be temporarily discontinued.
5. Other Medications
Inform your doctor about all medicines you are taking, including antihypertensives, diuretics, steroids, or thyroid medications, to prevent potential drug interactions.
6. Hypersensitivity
Avoid the medicine if you have a known allergy to Sitagliptin, Metformin, or any ingredients in the formulation.
7. Regular Monitoring
Periodic kidney function tests, blood sugar profiling, and Vitamin B12 assessment are recommended for patients on long-term therapy.
Conclusion
ST-GLIPTIN M 100/500 (Sitagliptin and Metformin Hydrochloride Tablets) offers a balanced, effective, and patient-friendly option for managing type 2 diabetes mellitus. Its dual-action formula not only improves blood glucose levels but also supports long-term metabolic health. When combined with lifestyle modifications, regular monitoring, and physician guidance, ST-GLIPTIN M 100/500 helps patients achieve better diabetic control and prevent long-term complications. Always use this medicine as prescribed and maintain routine follow-ups for safe and effective diabetes management.
